- Page 4 and 5: TÍTULO: Influencia de la época de
- Page 8 and 9: 1
- Page 10 and 11: Proyectada (Hariharan) Kaplan-Meier
- Page 12 and 13: 5
- Page 14: Trasplantes HURS 1979-2009 N=1136 T
- Page 17 and 18: 10
- Page 19 and 20: • • • • o
- Page 21 and 22: •
- Page 23 and 24: 16
- Page 25 and 26: • •
- Page 27 and 28: 20
- Page 29 and 30: • • •
- Page 31 and 32: • • •
- Page 33 and 34: RESULTADOS
- Page 35 and 36: 28
- Page 37 and 38: 2004 2003 2002 2001 2000 1999 1998
- Page 39 and 40: 150 120 120 100 80 Frequency 90 60
- Page 41 and 42: 35 50 30 40 Mean isq_fri 25 20 Tiem
- Page 43 and 44: Población total N=778 200 Donantes
- Page 45 and 46: 100 80 < 15/Sept/89 15/Sept/89 - 15
- Page 47 and 48: 40
- Page 49 and 50: Supervivencia Acumulada Trasplante
- Page 51 and 52: Tx Post Sept 2000 N=194 Tto no conv
- Page 53 and 54:
46
- Page 55 and 56:
o
- Page 57 and 58:
1,0 1,0 1,0 Supervivencia Acumulada
- Page 59 and 60:
o
- Page 61 and 62:
t_hospitalizacion 120 100 80 60 40
- Page 63 and 64:
56
- Page 65 and 66:
200 150 100 50
- Page 67 and 68:
í í 0 5 10 15 20 25
- Page 69 and 70:
62
- Page 71 and 72:
64
- Page 73 and 74:
66
- Page 75 and 76:
68
- Page 77 and 78:
Supervivencia Acumulada 1,0 0,8 0,6
- Page 79 and 80:
0 5 10 15 20 25 Sup 30/Nov/07 (Año
- Page 81 and 82:
74
- Page 83 and 84:
40 Máx PRA Pre No Si 50 Datos DGF
- Page 85 and 86:
78
- Page 87 and 88:
% Pacientes Vivos sin Diálisis 100
- Page 89 and 90:
82
- Page 91 and 92:
70 N=584 ¿Al 5 año post-Tx?
- Page 93 and 94:
86
- Page 95 and 96:
88
- Page 97 and 98:
90
- Page 99 and 100:
100 80 60 40 20 HURS ET UNOS CTS 0
- Page 101 and 102:
1,0 0,8 0,6 0,4 0,2 0,0 0 5 10 15 2
- Page 103 and 104:
96
- Page 105 and 106:
Vida Media N 16 14 12 10 8 6 4 2 0
- Page 107 and 108:
15 10 5 0 Vida Media Años 07/02/79
- Page 109 and 110:
Q1 Q2 Q3 Q4 Prop Mortalidad Acumula
- Page 111 and 112:
0,25 Q1 Q2 Q3 Q4 Potencial (Q1) Pol
- Page 113 and 114:
0,6 Q1 Q2 Q3 Q4 Potencial (Q1) Poli
- Page 115 and 116:
0,4 Q1 Q2 Q3 Q4 Lineal (Q1) Exponen
- Page 117 and 118:
25 20 15 10 5 Todos > 6 meses 0 1/S
- Page 119 and 120:
112
- Page 121 and 122:
114
- Page 123 and 124:
116
- Page 125 and 126:
3.I.A.
- Page 127 and 128:
Total 303 Pacientes 818 determinaci
- Page 129 and 130:
122
- Page 131 and 132:
200 182 200 164 150 150 100 100 50
- Page 133 and 134:
200 MDRD_6m_SN NO SI 200 MDRD_12m_S
- Page 135 and 136:
MDRD A_12meses 140 120 100 80 60 40
- Page 137 and 138:
40 120 100 30 80 N 20 N 60 40 10 20
- Page 139 and 140:
132
- Page 141 and 142:
134
- Page 143 and 144:
3.II.B.
- Page 145 and 146:
Supervivencia Acumulada Paciente 1,
- Page 147 and 148:
Supervivencia Acumulada Paciente 1,
- Page 149 and 150:
3.IV.A.
- Page 151 and 152:
144
- Page 153 and 154:
146
- Page 155 and 156:
3.V.A. Población T
- Page 157 and 158:
150
- Page 159 and 160:
• • •
- Page 161 and 162:
3.V.C.
- Page 163 and 164:
Supervivencia Acumulada Tx 1,0 0,8
- Page 165 and 166:
Supervivencia Acumulada Tx 1,0 0,8
- Page 167 and 168:
•
- Page 169 and 170:
Supervivencia Acumulada Paciente 1,
- Page 171 and 172:
Supervivencia Acumulada Tx 1,0 0,8
- Page 173 and 174:
• • •
- Page 175 and 176:
ggt.2 700 600 500 400 300 200 100 0
- Page 177 and 178:
170
- Page 179 and 180:
172
- Page 181 and 182:
174
- Page 183 and 184:
176
- Page 185 and 186:
178
- Page 187 and 188:
180
- Page 189 and 190:
182
- Page 191 and 192:
184
- Page 193 and 194:
186
- Page 195 and 196:
188
- Page 197 and 198:
190
- Page 199 and 200:
4.II.1. 4.II.2. 4.II.3.
- Page 201 and 202:
194
- Page 203 and 204:
196
- Page 205 and 206:
198
- Page 207 and 208:
200
- Page 209 and 210:
202
- Page 211 and 212:
4.III.2.
- Page 213 and 214:
IECA ARA II IECA o ARA II Supervive
- Page 215 and 216:
Supervivencia Acumulada Tx Sin Cens
- Page 217 and 218:
4.IV.1.
- Page 219 and 220:
70 60 Serologia_SN No SI 2005 2000
- Page 221 and 222:
Fosfatasa Alcalina 1500 1200 900 60
- Page 223 and 224:
216
- Page 225 and 226:
4.IV.2.
- Page 227 and 228:
220
- Page 229 and 230:
222
- Page 231 and 232:
224
- Page 233 and 234:
226
- Page 235 and 236:
228
- Page 237 and 238:
230
- Page 239 and 240:
232
- Page 241 and 242:
234
- Page 243 and 244:
236
- Page 245 and 246:
238